Loading...
•
Dec 31, 2024
Chemours Q4 2024 Earnings Report
Chemours reported a mixed performance in Q4 2024, with revenue slightly declining but Adjusted EBITDA improving.
Key Takeaways
Chemours saw a 1% YoY revenue decline in Q4 2024, impacted by lower pricing. However, Adjusted EBITDA grew by 2%, supported by cost efficiencies in Titanium Technologies and volume growth in Thermal & Specialized Solutions. Net loss improved to $8 million from $18 million in Q4 2023.
Revenue declined by 1% YoY to $1.36 billion due to lower pricing (-3%), partially offset by volume growth (+2%).
Thermal & Specialized Solutions (TSS) achieved record Q4 sales, with Opteon™ Refrigerants growing 23% YoY.
Adjusted EBITDA increased 2% to $179 million, reflecting cost savings and volume growth.
Net loss improved to $8 million from $18 million in Q4 2023.
Chemours
Chemours
Forward Guidance
Chemours expects Adjusted EBITDA to grow in FY 2025, driven by cost savings and segment growth, but faces challenges in pricing and demand fluctuations.
Positive Outlook
- TSS segment expected to see sequential sales growth in Q1 2025, led by Opteon™ Refrigerants.
- Corporate expenses expected to decline by 30% in Q1 2025.
- Operational efficiency initiatives to support profitability in Titanium Technologies.
- Cost savings from the TT Transformation Plan continue to have a positive impact.
- Adjusted EBITDA guidance for FY 2025 set between $825 million and $975 million.
Challenges Ahead
- Freon™ Refrigerants expected to decline due to regulatory transitions.
- Titanium Technologies segment projects lower sales in Q1 2025 due to regional sales mix.
- Advanced Performance Materials segment to face softer demand from hydrogen and semiconductor markets.
- Operational headwinds from cold weather downtime in January 2025.
- Potential cost pressures from ramping up Opteon™ capacity expansion.